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Abstract 
Uptake of penicillin-G has been studied in rabbit intestinal brush-border membrane vesicles (BBMV). Penicillin-G was transported 
into the lumen of BBMV via an H+-dependent, Na+-independent up ake system. This was a saturable carrier-mediated process, which 
adhered to Michaelis-Menten kinetics, having a pH optimum of 4.5 and resulting in a net-negative charge transfer. Vma x was 59 nmol 
penicillin-G (mg protein)-i (30 s)-1 and K m 22.7 mM. Ampicillin, penicillin-V, cefadroxil, cephalexin, cephalothin, cephradine, 
L-carnosine, glycyl-L-alanine, glycyl-L-tyrosine and glycylglycylglycine inhibited the uptake of penicillin-G. However, glycylsarcosine 
stimulated uptake by 92%. Countertransport experiments suggested that this effect took place at the active site of the transporter. 
Penicillin-G uptake appeared to be mediated via a common transport system shared by penicillins, cephalosporins and peptides. 
Keywords: Brush-border membrane vesicle; fl-Lactam; Antibiotic uptake; Penicillin-G; Oral administration; pH gradient 
I. Introduction 
Not all fl-lactam antibiotics are orally absorbed, but the 
precise reasons for this are as yet not known. They are 
hydrophilic weak acids containing a peptide bond and are 
completely ionised at the pH of the intestinal contents. On 
the basis of pH-partition theory and their chemical and 
physicochemical properties [1], fl-lactam antibiotics would 
be expected to be poorly absorbed from the small intestine. 
However, pharmacokinetic studies howed [2] that many of 
them were well absorbed. 
Passive diffusion through the paracellular pathway ap- 
peared to account only for a small amount of orally 
absorbed/3-1actams [3]. It appeared that they were actively 
transported across the brush-border membrane (BBM) of 
the enterocyte via a proton-dependent peptide carrier [4-13] 
and subsequently exited into the bloodstream via the baso- 
lateral membrane. Early studies showed that the transport 
of some hydrolysis-resistant di- and tripeptides (e.g., gly- 
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cylsarcosylsarcosine, L-carnosine, glycylsarcosine) was an 
active energy-requiring process [ 14,15]. Subsequent s udies 
in brush-border membrane vesicles (BBMV) showed that 
this process was carrier-mediated, saturable, adhered to 
Michaelis-Menten kinetics and could be competitively in- 
hibited by other di- and tripeptides and aminocepha- 
losporins [6,16-20]. Furthermore, peptide transport was 
shown to be stereospecific, independent from amino acid 
transport, and that hydrolysis and transport were distinct 
processes [4,10,21]. 
In 1985, Ganapathy and Leibach [21] postulated that 
peptides were co-transported with H ÷. The transport of 
such ions caused a depolarisation of the membrane poten- 
tial and led to a net transfer of positive charge [18,19]. The 
H+-gradient across the membrane of the intact intestinal 
cell is thought to be maintained by the Na+/H + ex- 
changer located in the BBM and the Na- /K  + ATPase in 
the basolateral membrane. Thus, peptide transport has been 
described as a 'tertiary active' transport system. 
Although it was thought that the a-amino acid at 
position 7 of the cephalosporin skeleton represented a key 
feature for the active transport of aminocephalosporins, 
recent studies have shown that cephalosporins lacking this 
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group, such as cefixime, FK089 and ceftibuten, were 
transported across the membrane of BBMVs [5-7,9- 
12,22]. The lack of the a-amino acid at position 7 makes 
these compounds anionic at physiological pH compared to 
other/3-1actam antibiotics which are zwitterions at this pH 
[1,9]. However, the pH microclimate at the BBM has been 
shown to be acidic [23], influencing the ionisation and 
subsequently the transport of peptides and /3-1actams. 
Small-intestinal H+/peptide carriers for human 
(hPepT1) [24] and rabbit small intestine (Peptl) [25] have 
recently been cloned. Another H+/peptide carrier, HPT-1, 
cloned from the human colorectal cell line (Caco-2) ap- 
pears to have a very different structure and might be 
associated with binding rather than transport functions, as 
it has been suggested to be related to the cadherin super- 
family [26]. However, all of these carriers were able to 
mediate peptide and /3-1actam uptake in a proton- 
gradient-dependent manner. 
The latest member of the H+/peptide cotransport fam- 
ily, PepT2, has been cloned from human kidney [27]. This 
transporter was distinct from that cloned from the human 
small intestine, displaying a 50% identity and a 70% 
homology and is not present in the human small intestine 
[27]. hPepT1 the human small-intestinal H+/peptide co- 
transporter was only marginally detectable in human kid- 
ney tissue [24]. 
It has now been established that many /3-1actam antibi- 
otics are taken up in the small intestine by an H+-driven 
peptide transport system [4-13,22,24,25] of which there 
may be more than one [6,7,10,13,16,22,24-26]. 
Penicillin [4] and one of its derivatives (ampicillin) [28] 
have as yet only been used as inhibitors or markers for the 
potential small-intestinal peptide transporter(s). To our 
knowledge there are no studies of the characteristics of
small-intestinal uptake of penicillin itself. In the present 
paper we have characterised the uptake and inhibition of 
penicillin-G transport and suggest its potential importance 
for the design of orally active /3-1actam antibiotics. 
2. Materials and methods 
2.1. Materials 
Mes, Hepes, EDTA, FCCP, valinomycin, cefotaxime, 
cephalothin and all peptides and amino acids were ob- 
tained from Fluka (Dorset, UK). Ampicillin was from 
Aldrich (Dorset, UK), penicillin-G, penicillin V, amoxi- 
cillin, cephalexin, cefuroxime, cephradine, cephadroxil, 
probenecid, Tris and DIDS from Sigma (Dorset, UK). 
BCA-protein assay was from Pierce Chemicals (Chester, 
UK) and glucose test kit from Merck (Darmstadt, Ger- 
many). Radiochemicals, benzyl[14C]penicillin potassium 
(specific activity 59 mCi/mmol) and D-[U-lac]glucose 
(spec. act. 292 mCi/mmol) were from Amersham (UK). 
Scintillation liquid 'OptiPhase safe' was from Wallac (Mil- 
ton Keynes, UK). All other chemicals were of the highest 
purity available. 
2.2. Animals 
New Zealand White male rabbits (2-2.5 kg) (Regal 
Rabbits, London, UK) were kept on a standard iet and 
water ad libitum until death. 
2.3. Preparation of  brush-border membrane vesicles from 
rabbit small intestine 
Rabbits were killed by cervical dislocation and approx. 
1 m of the proximal small intestine was removed, washed 
in ice-cold 0.9% NaC1, everted on a glass rod, cut into 2 
cm strips, snap-frozen in liquid nitrogen and stored at 
-80°C until use. Brush-border membrane vesicles from 
rabbit small intestine were prepared according to a modifi- 
cation of the salt precipitation method escribed by Kessler 
et al. [29] and Shirazi-Beechey t al. [30]. All the following 
steps were carried out at 4°C. On the day of use, the 
everted and frozen intestine was slowly defrosted, sus- 
pended in 10 mM Hepes/Tris, 40 mM mannitol at pH 7.1 
and mixed with a 'Vibromixer Type El '  (Chemap, 
Volketswil, Switzerland) at maximal output for 10 min. 
After coarse filtration, the suspension was further ho- 
mogenised using an Ultra-Turrax mixer (IKA-Werk, Ger- 
many) at maximal output for 5 min. MgC12 (final concen- 
tration 10 mM) was added to the homogenate which was 
stirred for 20 min and then centrifuged at 4000 X g for 15 
min. The supernatant was then centrifuged at 27 000 X g 
for 30 min. The resulting pellet was resuspended in 10 mM 
Hepes/Tris, 0.1 mM MgSO 4, 100 mM mannitol at pH 7.1 
using a 23 G needle and a 5 ml syringe, and the volume 
was adjusted to 200 ml. After centrifugation at 4000 X g 
for 15 min the supernatant was centrifuged at 27000 X g 
for 30 min. The pellet containing the BBMV was then 
resuspended using a 23 G needle, as before, in 50 ml of 
loading buffer, as indicated for each experimental set, and 
centrifuged at 27 000 × g for 30 min. The final pellet was 
resuspended in 5 ml of loading buffer required for the 
individual experimental sets by passing through a 23 G 
hypodermic needle several times. No loss of enzyme or 
transport activity was detected upon storage of BBMV in 
liquid nitrogen up to 18 weeks after preparation. 
2.4. Characterisation of  brush-border membrane vesicles 
The brush-border membrane marker enzymes K +- 
activated phosphatase [31], alkaline phosphatase [32], 
aminopeptidase N [33] and sucrase [34] were assayed by 
standard methods. Glucose liberated by sucrase was as- 
sayed using a commercial kit (Glucose GOD-PAP method, 
Merckotest 14365, Merck Diagnostica, Germany). Protein 
concentration was determined using a commercial kit based 
on the bicinchonic acid (BCA) method [35]. The integrity 
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of the BBMV was routinely tested by their ability to 
accumulate radiolabelled glucose in response to an Na +- 
gradient, as described previously [36]. 
2.5. Glucose uptake measurements 
D-[U-~4C]G lucose  uptake was carried out as previously 
described [33] with slight alterations. The loading buffer of 
the vesicles was 5 mM Hepes/Tris, 100 mM mannitol, 
100 mM KCI at pH 7.1. The assay buffer consisted of 100 
mM mannitol, 100 mM NaC1 (or 100 mM NaSCN), 5 mM 
Hepes/Tris at pH 7.1 and a final D-[U-14 C]glucose con- 
centration of 0.1 mM. Passive uptake was measured using 
assay buffer containing 100 mM KC1 instead of 100 mM 
NaC1. The transport studies were carried out at 37°C by 
mixing 10 /zl of vesicles with 100 /zl of assay mix. The 
reaction was stopped by adding 1 ml of 150 mM KCI, 5 
mM Hepes/Tris (pH 7.1) at 4°C and 1 ml of each assay 
was rapidly filtered through GSWP 0.22 /xm filters (Milli- 
pore, Watford, UK). After washing with 10 ml of ice-cold 
150 mM KC1, 5 mM Hepes/Tris (pH 7.1), the filters were 
dissolved in 4 ml of scintillation liquid and counted in a 
LKB 1219 Rackbeta (LKB, UK). The samples were cor- 
rected for reagent blank (non-specific binding to filters) 
and vesicle blank (zero-time uptake) allowing for non- 
specific binding to vesicles. 
2.6. Penicillin-G uptake 
Penicillin-G uptake was carried out as above with the 
following modifications; vesicles were loaded with 5 mM 
Hepes/Tris, 0.1 mM MgSO 4, 100 mM mannitol, 100 mM 
KC1 at pH 7.1; ~4C-labelled penicillin-G was diluted 1:10 
with unlabelled penicillin-G to give a final concentration 
of 0.1 mM in assay mix containing 100 mM KC1, 100 mM 
mannitol, 5 mM Mes/Tris for pH 5.0, or 5 mM Hepes/Tris 
for pH 7.1, respectively; samples were incubated at 37°C 
over a range of time points; stopping and washing buffer 
was 150 mM NaC1, 5 mM Hepes/Tris (pH 7.1) at 4°C. 
All the following experiments were carried out according 
to the same assay principle. 
2.7. Concentration dependency of penicillin-G uptake 
Penicillin-G concentration was increased by addition of 
unlabelled peniciilin-G. Changes in osmolarity due to in- 
creased penicillin-G concentration were corrected for by 
decreasing the mannitol concentration accordingly. Assay 
conditions are described in Fig. 2. Stopping and washing 
buffer was 125 mM NaC1, 50 mM Hepes/Tris (pH 7.1) at 
4°C. 
2.8. pH optimum of penicillin-G uptake 
The assay conditions are given in Fig. 3. Stopping and 
washing buffer was 125 mM NaC1, 50 mM Hepes/Tris 
(pH 7.1) at 4°C. 
Table 1 
Effect of various fl-lactam, peptides and 
uptake 
amino acids on penicillin-G 
Inhibitor (10 mM) % Uptake + S.D. (%) P 
Control (Pen-G 0.1 mM) 100 5 
Amoxicillin 86 6 < 0.001 
Ampicillin 42 9 < 0.001 
Penicillin-V 43 10 < 0.001 
Penicillin-G 64 9 < 0.001 
Cefadroxil 58 10 < 0.001 
Cephalexin 33 14 < 0.001 
Cephalothin 71 18 < 0.001 
Cephradine 82 5 < 0.001 
Cefotaxime 109 9 < 0.02 
Cefuroxime 104 18 > 0.05 
L-Carnosine 65 6 < 0.001 
Gly-L-AIa 48 7 < 0.001 
Gly-L-Tyr 52 13 < 0.001 
Gly-Gly 82 12 < 0.001 
Gly-Sar 192 8 < 0.001 
Gly-Gly-Gly 44 2 < 0.001 
Gly 88 15 < 0.05 
Sar 61 11 < 0.001 
Gly + Sar 75 6 < 0.001 
Probenecid (3 mM) 63 7 < 0.001 
The external buffer contained 50 mM Mes/Tris (pH 5.0), 100 mM KCI, 
40 mM mannitol (30 mM for glycine + sarcosine, 50 mM for control), 10 
mM inhibitor and 0.1 mM penicillin-G. The vesicles were loaded with 50 
mM mannitol, 100 mM KCI, 50 mM Hepes/Tris (pH 7.1) and 0.1 mM 
MgSO 4. The samples were incubated for 30 s at 37°C. Stopping and 
washing buffer was 125 mM NaCI, 50 mM Hepes/Tris (pH 7.1) at 4°C. 
The results represent the average of three distinct experiments carried out 
in triplicate. P values were calculated using the Student -test. 
2.9. Effect of osmolarity on penicillin-G uptake 
Osmolarity of the incubation medium was increased by 
addition of mannitol. Assay conditions are given in Fig. 4. 
Samples were incubated for 30 min at 37°C to ensure that 
the reaction was at equilibrium. Stopping and washing 
buffer was 125 mM NaC1, 50 mM Hepes/Tris (pH 7.1) at 
4°C. 
2.10. Inhibition of penicillin-G uptake 
Assay conditions are described in Table 1. Stopping and 
washing buffer was 125 mM NaCl, 50 mM Hepes/Tris 
(pH 7.1) at 4°C. Competitive inhibition and counter trans- 
port experiments were carried out as outlined in Figs. 5 
and 6, respectively. 
2.11. Effect of membrane potential on penicillin-G uptake 
Assays were carried out at 25°C for 30 s under the 
conditions as stated in Figs. 7-9. Stopping and washing 
buffer was 250 mM mannitol, 50 mM Hepes/Tris (pH 
7.1) at 4°C. 
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Fig. 1. Time-course of penicillin-G uptake in rabbit intestinal BBMV. 
Vesicles were loaded with 5 mM Hepes/Tris, 0.1 mM MgSO4, 100 mM 
mannitol, 100 mM KCI at pH 7.1. Assay mix contained 100 mM KCI, 
100 mM mannitol, 0.1 mM penicillin-G and 5 mM Mes/Tris for pH 5.0 
(ll I1), or 5 mM Hepes/Tris for pH 7.1 (O- -O) ,  
respectively. The samples were incubated at 37°C. Active transport is 
represented as A pH = pH 5.0-pH 7.1 (A---A). The results represent 
the average of three distinct experiments carried out in triplicate. Error 
bars represent s andard deviation (-4-S.D). 
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Fig. 2. Eadie-Hofstee plot of penicillin-G uptake in rabbit intestinal 
BBMV. Vesicles were loaded with 50 mM Hepes/Tris, 0.1 mM MgSO4, 
50 mM mannitol, 100 mM KC1 at pH 7.1. The external buffer contained 
100 mM KCI, 0-50 mM mannitol (to correct for penicillin-G addition), 
50 mM Mes/Tris (pH 5.0) and 0.1-50 mM penicillin-G . Samples were 
incubated for 30 s at 37°C. The results represent the average of three 
distinct experiments carried out in triplicate. Error bars represent +S.D. 
r = 0.830. 
3. Results 
cill in-G (mg protein)-1 (30 s)-1, gm 22.7 mM (Fig. 2) 
and had a pH optimum of 4.5 (Fig. 3). 
3.1. Vesicle characterisation and glucose uptake 3.3. Separation of  uptake and binding 
The purification factors of the marker enzymes were 
determined in three separate xperiments in triplicate and 
compared well with results achieved by other groups 
[29,30]. The enrichment factors were for K+-activated 
phosphatase 0.56 (S.D. + 0.53), alkaline phosphatase. 8 96 
(+ 0.95), aminopeptidase N 10.34 (___ 2.20) and sucrase 
11.95 (+0.53) .  At 30 s under a 100 mM NaCl-gradient 
glucose transport showed an overshoot 20-fold compared 
to the uptake at equilibrium. Under a 100 mM NaSCN 
gradient he maximal observed overshoot was at 15 s with 
a 55-fold uptake compared to equilibrium values. These 
results compare well with these of other groups [30]. 
3.2. Penicillin-G transport 
Under a pH gradient (pnoutsid e < pHinside) penicil l in-G 
exhibited the characteristic overshoot phenomenon (Fig. 
1), associated with active transport, as shown by many 
other studies on fl-lactams, peptides and peptide analogues 
[5-7,9,13,22,28]. Peak uptake of 485 pmol penicil l in-G 
(mg protein)-1 was achieved after 2 min and equilibrium 
was reached after 30 min. This compares well with the 
results of other groups using aminocephalosporins [5-  
7,9,13,22,28]. The uptake of penicil l in-G in absence of a 
pH-gradient (PHoutsid e= pHinside) increased steadily until 
reaching equilibrium after 60 min. The initial uptake of 
penicil l in-G (Fig. 1) was largely due to active transport (A 
pH 5 .0 -pH 7.1) and the rate reduced drastically after 2 
min. The active component of the uptake process con- 
formed to Michaelis-Menten kinetics: Vma x 59 nmol peni- 
Extrapolation to infinite osmolarity of the line relating 
equilibrium uptake to the reciprocal of the osmolarity of 
the external buffer suggested that more than 85% of 
penicil l in-G was transported into the vesicular space (Fig. 
4). FCCP (0.05 mM) reduced the active component of 
penicil l in-G uptake by 28% (S.D. + 4%) under a 50 mM 
KC1 gradient and by 50% (___ 5%) under a 50 mM KSCN 
gradient, assuming that the KSCN result in absence of 
FCCP represented 100% uptake (see Fig. 8). A similar 
result was found by Tsuji et al. [5] using cefixime. 
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Fig. 3. Effect of pH on penicillin-G uptake in rabbit intestinal BBMV. 
Vesicles were loaded with 50 mM Hepes/Tris, 0.1 mM MgSO4, 50 mM 
mannitol, 100 mM KCI at pH 7.1. The external buffer was 50 mM 
Mes/Tris (pH 4.0-6.5) or 50 mM Hepes/Tris (pH 7.1 and 8.0), 100 mM 
KCI, 50 mM mannitol and 0.1 mM penicillin-G. The samples were 
incubated for 30 s at 37°(2. The results represent the average of three 
distinct experiments carried out in triplicate. Error bars represent +S.D. 
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Fig. 4. Effect of osmolarity on penicillin-G uptake in rabbit intestinal 
BBMV. Vesicles were loaded with 50 mM Hepes/Tris, 0.1 mM MgSO4, 
50 mM mannitol, 100 mM KC1 at pH 7.1. The external buffer contained 
100 mM KC1, 50-550 mM mannitol, 50 mM Mes/Tris (pH 5.0) and 0.1 
mM penicillin-G. Samples were incubated for 30 minutes at 37°C. The 
results represent the average of three distinct experiments carried out in 
triplicate. Error bars represent 5: S.D. r = 0.945. 
3.4. Inhibition of penicillin-G transport 
Penicillin-G uptake was inhibited by: penicillin V, 
ampicillin, cephalothin, cephalexin, cephradine and 
cephadroxil (see Table 1). The two poorly absorbed 
cephalosporins, cefuroxime and cefotaxime, had no in- 
hibitory effect. Kinetic plots indicated that cephalexin was 
a competitive inhibitor of penicillin-G uptake (Fig. 5). 
Of the peptides used, L-carnosine, glycyl-c-tyrosine, 
glycylglycine, glycyl-L-alanine and glycylglycylglycine i - 
hibited penicillin-G uptake (Table 1). However, glycylsar- 
cosine stimulated penicillin-G uptake by 92%. Sugawara et 
al. [13] have reported a 30% stimulation of cephalexin 
uptake by glycylsarcosine. The action is thought o take 
~'1.5 
~. T ¸ 
~0.5  
~.0  i I 
0 1 2 
I/[S] mM Pen-G 
Fig. 5. Effect of 0 (/5/ /~, r = 0.998), 5 (•  • ,  
r = 0.996) and 10 mM (A ~ A, r = 0.975) cephalexin on peni- 
cillin-G transport in rabbit intestinal BBMV. The external buffer con- 
tained 50 mM Mes/Tris (pH 5.0), 100 mM KCI, 35-49.7 mM mannitol, 
0 mM, 5 mM, 10 rnM cephalexin, respectively, and 0.4 to 5.1 mM 
penicillin-G. Vesicles were loaded with 50 mM Hepes/Tris, 0.1 mM 
MgSO4, 50 mM mannitol, 100 mM KC1 at pH 7.1. The samples were 
incubated for 30 s at 37°C. The results represent the average of three 
distinct experiments carried out in triplicate. Error bars represent -l-S.D. 
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Fig. 6. Counter transport effect of 10 mM glycylsarcosine onpenicillin-G 
uptake in rabbit intestinal BBMV. The external buffer for the controls 
contained 50 mM Mes/Tris (pH 5.0), 100 mM KCI, 50 mM mannitol, 1 
mM glycylsarcosine and 0.1 mM penicillin-G (ml - - •  ). Vesi- 
cles for the controls were loaded with 50 mM Hepes/Tris, 0.1 mM 
MgSO 4, 50 mM mannitol, 100 mM KCI at pH 7.1. The external buffer 
for the counter transport contained 50 mM Mes/Tris (pH 5.0), 100 mM 
KC1, 50 mM and 0.1 mM penicillin-G (E/ D). Vesicles for 
the counter transport were loaded with 50 mM Hepes/Tris, 0.1 mM 
MgSO 4, 50 mM mannitol, 100 mM KCI at pH 7.1 and 10 mM glycylsar- 
cosine. The samples were incubated for 30 s at 37°C. The results 
represent the average of three distinct experiments carried out in tripli- 
cate. Error bars represent + S.D. 
place at the active site of the transporter, since effiux of 
glycylsarcosine from preloaded BBMV reduced the uptake 
of penicillin-G (Fig. 6). 
The two amino acids, glycine and sarcosine, gave dif- 
ferent results (Table 1). Glycine did not inhibit penicillin-G 
uptake very well, which agreed with reports that peptide 
and/3-1actam antibiotic transport was independent of amino 
acid transport [5,7,10,11,37]. However, sarcosine gave an 
inhibition of 40%. When using equimolar quantities (10 
raM) of glycine and sarcosine together, an inhibition of 
25% was observed. The reasons for this latter result were 
unclear. 
The addition of probenecid (3 raM), an inhibitor of 
penicillin excretion in the kidney, inhibited penicillin-G 
uptake by approximately 40% (Table 1). This suggests that 
the transporters esponsible for uptake in the small intes- 
tine and secretion in the renal tubule share some common 
features, although transport is mediated by two distinct 
transporters [24,27]. 
3.5. Effect of membrane potential on penicillin-G uptake 
Vesicles were loaded with mannitol and Hepes/Tris. 
The electrochemical gradient was altered by varying the 
composition of the (external) ion gradients across the 
vesicular membrane. Changing the cation gradient (50 
raM) from K + to Na + led to a reduction of 20% (S.D. + 
4%) of penicillin-G uptake, irrespective of the anion pre- 
sent, showing that penicillin uptake was not energised by 
an Na + gradient. Compared to the uptake of penicillin-G 
under the influence of a proton gradient alone, expressed 
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Fig. 7. Effect of 1 /zM valinomycin on penicillin-G uptake in rabbit 
intestinal BBMV. The external buffer contained 50 mM Mes/Tris (pH 
5.0), 250 mM mannitol, 0.1 mM penicillin-G. The vesicles were loaded 
with 50 mM mannitol, 100 mM KCI, 50 mM Hepes/Tris (pH 7.1) and 
0.1 mM MgSO 4. Valinomycin ( [] - -  [] ) in ethanol was added to 
the vesicles to give a final concentration of 1 /zM (in assay) and 
incubated for 5 min at 25°C prior to use. Control (•  - - •  ) 
samples were incubated as valinomycin samples in the presence of 0.5% 
ethanol. The samples were incubated at 25°C. The results represent the 
average of three distinct experiments carried out in triplicate. Error bars 
represent + S.D. 
as 100%, changes in the anion composition led to dramatic 
changes in penicillin-G uptake (see Fig. 9). The more 
permeable the anion, the greater the reduction in uptake: 
SO42-, -14% (S.D._ 11%), CI-, -20% (___5%) and 
SCN-, -52% (+4%), independent of the cation (Na ÷ or 
K ÷) present. Penicillin-G uptake thus appeared to result in 
a net negative charge transfer. Similar results were ob- 
served in studies using cefixime [5]. 
+ 
Furthermore, collapse of a K + gradient (Kinside > 
100 
P < 0.001 P < 0.001 
r I I 1 
m ~" 75 
d l l  
= 50 
25 
0 
KCI KCI + FCCP KSCN KSCN + FCCP 
Fig. 8. Effect of 0.05 mM FCCP on penicillin-G uptake in rabbit small 
intestinal BBMV. The internal buffer was 50 mM Hepes/Tris, 250 mM 
mannitol, at pH 7. I. BBMV were preincubated with either 0.5 mM FCCP 
(final concentration of 0.05 raM) and 0.5% ethanol or 0.5% ethanol 
(control) at 25°C for 5 rain prior to use. The external buffer was 50 mM 
Mes/Tris (pH 5.0), 150 mM mannitol, 50 mM KCI (or KSCN), 0.I mM 
penicillin-G. Samples were incubated for 30 s at 25°C. The results 
represent the average of three distinct experiments carried out in tripli- 
cate. Error bars represent ±S.D. P values were calculated using the 
Student -test. 
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Fig. 9. Effect of anion displacement on penicillin-G uptake in rabbit small 
intestinal BBMV. The external buffer contained 50 mM Mes/Tris (pH 
5.0), 150 mM mannitol (100 mM for K2SO4), 0.1 mM penicillin-G, 
0.5% ethanol and 50 mM K2SO4, KCI or KSCN, respectively. The 
vesicles were loaded with 250 mM mannitol, 50 mM Hepes/Tris (pH 
7.1) and 0.1 mM MgSO 4. The samples were incubated for 30 s at 25°C. 
The results represent the average of three distinct experiments carried out 
in triplicate. Error bars represent -I-S.D. P values were calculated using 
the Student -test. 
Ko+tside ) using valinomycin greatly reduced uptake com- 
pared to control (Fig. 7). 
4. Discussion 
Penicillin-G has been shown not to be bioavailable in 
man due to instability in the strongly acidic environment 
of the stomach. Penicillin-V is acid-stable and can be 
dosed orally. Penicillin-G was used in the present studies 
since penicillin-V and other penicillins were not available 
in an isotopically labelled form. 
The structural differences between penicillin-G and 
penicillin-V are trivial and do not involve the position 
traditionally associated with intestinal transport of/3-1actam 
antibiotics. The fact that penicillin-V inhibited penicillin-G 
uptake suggests that they share the same carrier. 
When fl-lactam antibiotics and peptides were used as 
inhibitors of penicillin-G uptake it was found that the 
standard buffer concentration of 10 mM Mes/Tris for pH 
5.0, as used by other groups [5-7,9-13,22,28], was too 
low to allow for the buffer capacity of the individual 
inhibitors. All the inhibitors used were by nature buffers 
themselves, which could have an effect on the imposed 
proton gradient. Thus, we used buffer concentrations of 50 
mM. 
The purified vesicles were enriched in BBM marker 
enzymes and no purification of basolateral marker en- 
zymes was observed. The glucose transport studies howed 
that the BBMV used in these experiments have intact 
transport capabilities. The initial uptake rate of penicillin-G 
was markedly stimulated by the presence of an H ÷ gradi- 
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ent. Collapsing the H-- gradient with FCCP led to a 
reduction of penicillin-G uptake by almost 30% or 50%, 
depending on the anion present, indicating that penicillin-G 
uptake is driven by a proton-gradient-dependent mecha- 
nism. The large majority of initial penicillin-G uptake was 
via an active transport system, which was saturable, and 
displayed Michaelis-Menten kinetics. The response to os- 
molar shrinkage suggested that more than 85% of peni- 
cillin-G was taken up into the lumen of the vesicles rather 
than being bound to the membrane. 
Ion substitution experiments suggested that the mem- 
brane potential is of importance. It has been previously 
reported that peptide [18,19] and cephalosporin [21] uptake 
was linked to a net positive charge transfer. Our studies 
suggest hat penicillin-G uptake resulted in a net negative 
charge transfer, similar to that previously observed with 
cefixime [5]. This difference is probably because cefixime 
and penicillin-G are negatively charged (anionic) at pH 5.0 
compared to the other peptides and cephaloporins tested 
[8,18,19] which are neutral (zwitterions). This suggests that 
the net negative charge transfer was a result of the uptake 
of the anionic form of penicillin-G. These results were 
further substantiated by using valinomycin. In vesicles 
loaded with KC1, collapse of the resulting K + gradient 
+ + 
(Kinside > Koutsid e) reduced penicillin-G uptake due to the 
resulting interior negative charge. 
Of the orally active /3-1actam antibiotics tested for their 
inhibitory effects, ampicillin, penicillin-V, cefadroxil, 
cephalexin and cephalothin gave inhibitory effects ranging 
from 30% to almost 70%. Although amoxicillin was twice 
as effectively absorbed in man than ampicillin [38], hardly 
any inhibitory effect was observed. A similar result was 
found for cephradine. There is some evidence [7] that 
cephradine has different ransport characteristics or even a 
different uptake system from cefixime. The presence of 
different transporters might explain the only slight in- 
hibitory effect of either amoxicillin or cephradine on peni- 
cillin-G uptake. However, this warrants further investiga- 
tion. Of the peptides used, L-carnosine, glycyl-L-alanine, 
glycyl-L-tyrosine and glycylglycylglycine showed in- 
hibitory effects ranging from 35% to 65%. Glycylglycine 
displayed hardly any inhibitory effects, whereas glycylsar- 
cosine stimulated uptake by over 90%. A less marked 
stimulatory effect (35%) of glycylsarcosine has been re- 
ported in experiments using cephalexin [13]. Cephalexin 
was by far the most potent inhibitor (67%) of penicillin-G 
uptake; either structural analogy or net charge could be of 
importance for this phenomenon. Since sarcosine is a 
derivative of glycine, the only slight inhibitory effect of 
glycylglycine compared to the other peptides could be 
explained in terms of structural similarity between glycyl- 
sarcosine and glycylglycine. Counter transport studies 
showed that glycylsarcosine efflux from BBMV inhibited 
the uptake of penicillin, indicating that the interaction was 
likely to take place at the active site of the transporter. 
However, the characteristics and the mechanism of this 
stimulation are as yet not understood and are currently 
under further investigation. 
In conclusion, penicillin-G uptake in rabbit small-in- 
testinal BBMV was mediated by a proton-gradient-driven, 
saturable active transport system resulting in a net negative 
charge transfer which can be inhibited by various/3-1actams 
and dipeptides, and stimulated by glycylsarcosine. These 
findings may be of importance in the administration of 
orally active /3-1actam antibiotics, as well as for rational 
design of new orally absorbed antibiotics. 
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